20 Feb 2025
22m

With three approved products and filings for more over the near term, Axsome's CEO describes the scale and reach this company is building in the CNS space

Podcast cover

BiotechTV - News

Open in Podwise to generate AI notes

Sign in to process this episode and unlock summaries, transcripts, highlights and translations.

Open in Podwise

Shownotes are not generated by Podwise.

With three approved products and filings for more over the near term, Axsome's CEO describes the scale and reach this company is building in the CNS space